Likewise, reports on the stem cell-associated transcription factor OCT4 have shown that OCT4 overexpression resulted in worse OS for patients with rectal cancer [21] and worse progression-free survival (PFS) for patients with gastric cancer [22]. This evidence concerns the gene POU5F1 and rectal cancer.